Amneal Pharmaceuticals, Inc. (AMRX) › Operating Cash FlowAmneal Pharmaceuticals, Inc. (AMRX) — Operating Cash FlowAnnual figures by period end, from SEC filings.2016-12-31: $115.06M2017-12-31: $234.19M2018-12-31: $250.23M2019-12-31: $1.71M2020-12-31: $379.00M2021-12-31: $241.82M2022-12-31: $65.10M2023-12-31: $345.58M2024-12-31: $295.10M2025-12-31: $339.99M$339.99M2016-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$339.99M+15.2%2026-02-27From 2025-01-012024-12-31$295.10M-14.6%2026-02-27From 2024-01-012023-12-31$345.58M+430.8%2026-02-27From 2023-01-012022-12-31$65.10M-73.1%2025-02-28From 2022-01-012021-12-31$241.82M-36.2%2024-03-14From 2021-01-012020-12-31$379.00M+22128.8%2023-03-03From 2020-01-012019-12-31$1.71M-99.3%2022-03-01From 2019-01-012018-12-31$250.23M+6.9%2021-03-01From 2018-01-012017-12-31$234.19M+103.5%2020-03-02From 2017-01-012016-12-31$115.06M—2019-03-01From 2016-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)